0000000000911535

AUTHOR

Thomas Muenzel

showing 14 related works from this author

A first dedicated heart valve unit: safe and streamlined patient care for the rapidly growing field of transcatheter heart valve interventions

2021

Abstract Background A dedicated Heart Valve Unit was launched in 2018 to meet the demands of the growing transcatheter heart valve program by optimizing patient care in a single dedicated unit. Purpose To assess the performance of the heart valve unit (all steps of patient care in a single unit with intermediate care facilities) over a conventional approach (preparation on a normal ward, postprocedural intensive care unit (ICU) monitoring and transfer to an additional monitoring ward before discharge) in a high volume center. Methods Retrospective analysis including patients undergoing transcatheter mitral or tricuspid valve repair who were admitted to the Heart Valve Unit (02/2018–01/2020)…

medicine.medical_specialtyTricuspid valvebusiness.industryPsychological interventionHospital mortalityIntermediate Care FacilityIntensive care unitPatient carelaw.inventionmedicine.anatomical_structurelawmedicinePathologic fistulaHeart valveCardiology and Cardiovascular MedicineIntensive care medicinebusinessEuropean Heart Journal
researchProduct

Tubulin-folding cofactor E deficiency is associated with vascular dysfunction and endoplasmatic reticulum stress of vascular smooth muscle cells

2021

Abstract Introduction Endothelial function assessed via flow mediated dilatation (FMD) has shown to predict risk in individuals with established cardiovascular diseases, whereas its predictive value is uncertain in the setting primary prevention. Purpose The aim of the current work was to discover and evaluate novel mediators of vascular dysfunction in the general population and in conditional knock-out transgenic animal models. Methods In order to identify novel targets that were negatively correlated with FMD and investigate their contribution in vascular function, a Genome Wide Association Study (GWAS) of 5,000 participants was performed and subsequently immune cell-, endothelial- and va…

Tubulin foldingVascular smooth musclebusiness.industryMedicineCOFACTOR ECardiology and Cardiovascular MedicinebusinessReticulumCell biologyEuropean Heart Journal
researchProduct

P798Outcome of percutaneous coronary intervention with everolimus-eluting bioresorbable vascular scaffolds in patients with STEMI as compared to stab…

2018

medicine.medical_specialtyEverolimusbusiness.industrymedicine.medical_treatmentPercutaneous coronary interventionlanguage.human_languageGermanInternal medicineStable cadCardiologylanguageMedicineIn patientCardiology and Cardiovascular Medicinebusinessmedicine.drugEuropean Heart Journal
researchProduct

Troponin I Assay for Identification of a Significant Coronary Stenosis in Patients with Suspected Acute Myocardial Infarction and Wide QRS Complex

2016

Background Common ECG criteria such as ST-segment changes are of limited value in patients with suspected acute myocardial infarction (AMI) and bundle branch block or wide QRS complex. A large proportion of these patients do not suffer from an AMI, whereas those with ST-elevation myocardial infarction (STEMI) equivalent AMI benefit from an aggressive treatment. Aim of the present study was to evaluate the diagnostic information of cardiac troponin I (cTnI) in hemodynamically stable patients with wide QRS complex and suspected AMI. Methods In 417 out of 1818 patients presenting consecutively between 01/2007 and 12/2008 in a prospective multicenter observational study with suspected AMI a pro…

MaleCardiovascular ProceduresMyocardial Infarctionlcsh:MedicineCoronary Artery Disease030204 cardiovascular system & hematologyPathology and Laboratory MedicineBiochemistryVascular MedicineCoronary artery diseaseElectrocardiographyPatient Admission0302 clinical medicineTroponin IMedicine and Health SciencesMedicine030212 general & internal medicineMyocardial infarctionlcsh:ScienceStenosisMultidisciplinarymedicine.diagnostic_testbiologyMiddle AgedTroponinBioassays and Physiological Analysiscardiovascular systemCardiologyFemaleAlgorithmsResearch Articlemedicine.medical_specialtyCardiologySurgical and Invasive Medical ProceduresResearch and Analysis MethodsSensitivity and Specificity03 medical and health sciencesSigns and SymptomsDiagnostic MedicineInternal medicineHumansddc:610cardiovascular diseasesAgedCoronary RevascularizationBundle branch blockReceiver operating characteristicbusiness.industryRevascularizationElectrophysiological TechniquesAngioplastyTroponin Ilcsh:RCoronary StenosisBiology and Life SciencesProteinsmedicine.diseaseTroponinCytoskeletal Proteinsbiology.proteinMyocardial infarction complicationslcsh:QCardiac ElectrophysiologybusinessCoronary AngioplastyElectrocardiographyBiomarkersPLOS ONE
researchProduct

Comparison of Linagliptin, Sitagliptin and Liraglutide Effects on Survival and Vascular Complications in Experimental Sepsis

2013

medicine.medical_specialtyLiraglutidebusiness.industryUrologyLinagliptinmedicine.diseaseBiochemistrySepsisEndocrinologySitagliptinInternal medicinePhysiology (medical)medicinebusinessmedicine.drugFree Radical Biology and Medicine
researchProduct

Effect of comprehensive vasodilation vs usual care on mortality and heart failure rehospitalization in women with acute heart failure

2020

Abstract Background Guidelines recommend evaluating the risk/benefit ratio of novel therapies individually in women and men, as the pathophysiology and the response to treatment may differ between women and men. Among patients with acute heart failure (AHF), a strategy of intensive vasodilation, compared with usual care, overall did provide comparable outcomes. Purpose To evaluate the effect of a strategy that emphasized early intensive and sustained vasodilation in women with AHF. Methods In a randomized, open-label blinded-end-point trial patients hospitalized for AHF were enrolled in 10 hospitals in Switzerland, Bulgaria, Germany, Brazil, and Spain. Inclusion criteria were AHF expressed …

medicine.medical_specialtybusiness.industryVasodilationmedicine.diseasePatient roomPharmacotherapyBlood pressurePlasma drug concentrationInternal medicineHeart failureUsual caremedicineCardiologyCardiology and Cardiovascular MedicineAdverse effectbusinessEuropean Heart Journal
researchProduct

Abstract 13812: Pulmonary Function Predicts Cardiac Function, Structure & Clinical Outcome in Chronic Heart Failure: Results From the Myovasc Stu…

2020

Introduction: A growing body of evidence suggests a relevance of pulmonary function in the pathophysiology of heart failure (HF). Comprehensive data on the role of forced expiratory volume in 1 second (FEV1) in the development & progression of HF is limited. Hypothesis: Given this background, we hypothesized, that (FEV1) is associated with deteriorated left ventricular (LV) functional as well as structural status, & predicts specific clinical outcome in HF. Methods: Data from the MyoVasc Study (n=3,289) were analysed. Comprehensive clinical phenotyping including body plethysmography for the evaluation of FEV1 & standardized echocardiography were performed during a five-hour inv…

Cardiac function curvemedicine.medical_specialtybusiness.industrymedicine.diseaseOutcome (game theory)PathophysiologyPulmonary function testingPhysiology (medical)Internal medicineHeart failureEpidemiologyCardiologymedicineCardiology and Cardiovascular MedicinebusinessCirculation
researchProduct

Effect of antihypertensive treatment with a combination of telmisartan and amlodipine on vascular structure and function

2013

medicine.medical_specialtyEndotheliumbusiness.industrymedicine.diseaseBlood pressureHYDROCHLOROTHIAZIDE/OLMESARTANmedicine.anatomical_structureInternal medicineArterial stiffnessmedicineCardiologyVascular structureAmlodipineTelmisartanEndothelial dysfunctionCardiology and Cardiovascular Medicinebusinessmedicine.drugEuropean Heart Journal
researchProduct

Thirty-one novel biomarkers as predictors for clinically incident diabetes.

2010

Background The prevalence of diabetes is increasing in all industrialized countries and its prevention has become a public health priority. However, the predictors of diabetes risk are insufficiently understood. We evaluated, whether 31 novel biomarkers could help to predict the risk of incident diabetes. Methods and Findings The biomarkers were evaluated primarily in the FINRISK97 cohort (n = 7,827; 417 cases of clinically incident diabetes during the follow-up). The findings were replicated in the Health 2000 cohort (n = 4,977; 179 cases of clinically incident diabetes during the follow-up). We used Cox proportional hazards models to calculate the relative risk of diabetes, after adjustin…

AdultMaleRiskmedicine.medical_specialtyDiabetes riskPublic Health and Epidemiologylcsh:Medicine030209 endocrinology & metabolism030204 cardiovascular system & hematologyCohort Studies03 medical and health sciences0302 clinical medicineSex FactorsPredictive Value of TestsDiabetes mellitusInternal medicinemedicineDiabetes MellitusHumansCardiovascular Disorders/Vascular Biologylcsh:ScienceAgedApolipoproteins BProportional Hazards ModelsMultidisciplinaryAdiponectinbiologyProportional hazards modelbusiness.industrylcsh:RC-reactive proteinMiddle Agedmedicine.disease3. Good healthDiabetes and EndocrinologyC-Reactive ProteinROC CurveRelative riskImmunologyCohortFerritinsbiology.proteinlcsh:QFemaleAdiponectinbusinessBiomarkersCohort studyResearch ArticlePloS one
researchProduct

2861Role of glycemic state for the relationship between abdominal obesity and markers of inflammation and hemostasis in the population

2017

medicine.medical_specialtyeducation.field_of_studybusiness.industryPopulationInflammationGastroenterologySurgeryHemostasisInternal medicinemedicinemedicine.symptomCardiology and Cardiovascular MedicineeducationHemostatic functionbusinessAbdominal obesityGlycemicEuropean Heart Journal
researchProduct

Discordance in prognostic ability between physician assessed NYHA classification and self-reported health status in patients with acute heart failure

2021

Abstract Background Especially in patients with acute heart failure (AHF) the NYHA classification remains of uncertain representation of patients' actual health state. Alternatively, patient's subjective well-being, in terms of health-related quality of life (HRQL), showed to have an excellent prognostic ability in out clinic patients with chronic heart failure. Objectives It is unknown whether HRQL instruments can assess a more reliable prognostication in patients hospitalized due to AHF than the NYHA classification. Methods Goal Directed Afterload Reduction in Acute Congestive Cardiac Decompensation Study (GALACTIC) was a multicenter, randomized, open-label blinded-end-point trial that em…

medicine.medical_specialtybusiness.industryInternal medicineHeart failureNYHA classificationMedicineIn patientCardiology and Cardiovascular Medicinebusinessmedicine.diseaseEuropean Heart Journal
researchProduct

Vascular Dysfunction and Oxidative Stress in Diabetic Rats - Comparison of Beneficial Effects of AT1- Receptor Blockade, Calcium Antagonist, or Combi…

2013

medicine.medical_specialtyCombination therapybusiness.industryAntagonistchemistry.chemical_elementPharmacologyCalciummedicine.disease_causeBiochemistryEndocrinologyAt1 receptor blockadechemistryPhysiology (medical)Internal medicinemedicinebusinessBeneficial effectsOxidative stressFree Radical Biology and Medicine
researchProduct

Der GALACTIC-Trial

2015

Ziel der Studie ist zu untersuchen, ob bei normo- bis hypertensiver akuter Herzinsuffizienz eine therapeutische Strategie, basierend auf einer fruhen, zielgerichteten Senkung der Vor- und Nachlast mittels aggressiver Vasodilatation, in einem nicht-ICU-Setting sicher durchgefuhrt werden kann, und ob dies zu einer Verbesserung der Symptomatik und Prognose fuhrt.

Swiss Medical Forum ‒ Schweizerisches Medizin-Forum
researchProduct

Effects of alirocumab on types of myocardial infarction : insights from the ODYSSEY OUTCOMES trial

2019

Gislason, Gunnar H/0000-0002-0548-402X; Malynovsky, Yaroslav V/0000-0002-9118-1104; Bhatt, Deepak L./0000-0002-1278-6245; Nikolaev, Konstantin/0000-0003-4601-6203; Sherwood, Matthew/0000-0002-4305-5883; Chumakova, Galina A/0000-0002-2810-6531; Raffel, Owen C/0000-0001-5470-7050; Leonardi, Sergio/0000-0002-4800-6132; Tse, Hung Fat/0000-0002-9578-7808; Reshetko, Olga/0000-0003-3107-7636; Pereira, Helder/0000-0001-8656-4883; Racca, Vittorio/0000-0002-4465-3789; Podoleanu, Cristian/0000-0001-9987-2519; Ersanli, Murat/0000-0003-1847-3087; Muenzel, Thomas/0000-0001-5503-4150; Sandhu, Manjinder/0000-0003-2538-2079; Taskinen, Marja-Riitta/0000-0002-6229-3588; bastos, jose/0000-0002-9526-3123; Manak…

MaleBIOMEDICINE AND HEALTHCARE. Clinical Medical Sciences.Cardiac & Cardiovascular SystemsMyocardial InfarctionUNIVERSAL DEFINITION030204 cardiovascular system & hematologyTHERAPYDISEASEchemistry.chemical_compound0302 clinical medicineCardiac and Cardiovascular Systems030212 general & internal medicineMyocardial infarctionProspective Studies1102 Cardiorespiratory Medicine and HaematologyOxygen supplyKardiologiBIOMEDICINA I ZDRAVSTVO. Kliničke medicinske znanosti.CHOLESTEROLMiddle AgedMI typesCardiologyLDL Cholesterol LipoproteinsFemaleCardiology and Cardiovascular MedicineLife Sciences & Biomedicinemedicine.medical_specialty610ODYSSEY OUTCOMES InvestigatorsAntibodies Monoclonal HumanizedCLASSIFICATION03 medical and health sciencesDouble-Blind MethodInternal medicinemedicineHumansddc:610Alirocumab ; MI types ; Mortality ; PreventionMortalityMETAANALYSISAlirocumabAgedScience & TechnologyTask forceCholesterolbusiness.industryEVOLOCUMABPrevention1103 Clinical SciencesCholesterol LDLmedicine.diseaseEvolocumabchemistryCardiovascular System & HematologyCardiovascular System & CardiologyHuman medicinebusinessAlirocumab
researchProduct